In 2025, India’s IPO market continues to evolve, and Fabtech Technologies Ltd., a prominent player in biopharma engineering, is gearing up for its IPO launch. The Fabtech Technologies IPO opens on September 29, 2025, and closes on October 1, 2025. This IPO offers investors an opportunity to back a company with strong growth prospects in the cleanroom technology and biopharma sectors.
About Fabtech Technologies Ltd.
Incorporated in 2018, Fabtech Technologies Ltd. provides end-to-end turnkey solutions in the biopharma sector, offering services such as cleanroom facilities, modular systems, HVAC systems, and customised engineering solutions. With expertise in compliance with international regulatory standards, Fabtech Technologies caters to global clients, including the life sciences, food and beverage, IT, semiconductor, and aeronautics sector.
The company provides solutions across the bio-pharma manufacturing lifecycle, including design, engineering, manufacturing, installation, and project management. Its focus areas include clean air and clean water solutions, as well as HVAC systems tailored to specific industrial needs.
As of July 31, 2025, Fabtech Technologies has 185 permanent employees and is expanding its market reach, executing projects across diverse and challenging geographies.
Competitive Strengths:
- Expertise in turnkey engineering solutions
- In-house software technology capabilities
- Diversified order book across multiple business verticals
- Strong leadership team with Fabtech Group parentage
- Track record of executing projects across all dosage forms
Fabtech Technologies IPO Details
The Fabtech Technologies IPO is a book-building issue of ₹230.35 crore, with a fresh issue of 1.21 crore shares. The IPO will be listed on BSE and NSE.
IPO Timeline:
| Event | Date (Tentative) |
| IPO Open Date | Sep 29, 2025 |
| IPO Close Date | Oct 1, 2025 |
| Tentative Allotment | Oct 3, 2025 |
| Initiation of Refunds | Oct 6, 2025 |
| Credit of Shares to Demat | Oct 6, 2025 |
| Tentative Listing Date | Oct 7, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Oct 1, 2025 |
Key IPO Details:
| Parameter | Details |
| Face Value | ₹10 per share |
| Issue Price Band | ₹181 – ₹191 per share |
| Lot Size | 75 shares |
| Total Issue Size | 1.21 crore shares (₹230.35 Cr) |
| Sale Type | Fresh Issue |
| Employee Discount | ₹9 per share |
| Issue Type | Bookbuilding IPO |
| Shareholding Pre-Issue | 3.23 crore shares |
| Shareholding Post-Issue | 4.44 crore shares |
Investor Category Reservation:
- QIB: Not more than 50%
- Retail: Not less than 35%
- NII: Not less than 15%
Lot Size & Investment:
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 75 | ₹14,325 |
| Retail (Max) | 13 | 975 | ₹1,86,225 |
| S-HNI (Min) | 14 | 1,050 | ₹2,00,550 |
| S-HNI (Max) | 69 | 5,175 | ₹9,88,425 |
| B-HNI (Min) | 70 | 5,250 | ₹10,02,750 |
Promoter Holding:
The company’s promoters are Aasif Ahsan Khan, Hemant Mohan Anavkar, Aarif Ahsan Khan, and Manisha Hemant Anavkar.
- Pre-IPO: 94.61%
- Post-IPO: NA
Book Running Lead Manager: Unistone Capital Pvt. Ltd.
Registrar: Bigshare Services Pvt. Ltd.
Fabtech Technologies Ltd.: Financials
Financial Highlights (₹ Crore):
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 426.56 | 269.24 | 213.86 |
| Total Income | 335.94 | 230.39 | 199.91 |
| Profit After Tax | 46.45 | 27.22 | 21.73 |
| EBITDA | 47.28 | 40.69 | 34.86 |
| Net Worth | 173.11 | 131.88 | 88.96 |
| Reserves & Surplus | 140.72 | 128.94 | 86.18 |
| Total Borrowing | 54.62 | 9.88 | 34.29 |
Key Performance Indicators (FY2025):
| KPI | Value |
| Market Capitalisation | ₹849.04 Cr |
| ROE (Return on Equity) | 30.46% |
| ROCE (Return on Capital Employed) | 24.46% |
| Debt/Equity | 0.32 |
| RoNW (Return on Net Worth) | 26.83% |
| PAT Margin | 13.83% |
| EBITDA Margin | 14.07% |
| Price to Book Value | 3.57 |
| EPS Pre-IPO | ₹14.34 |
| EPS Post-IPO | ₹10.45 |
| P/E Pre-IPO | 13.32x |
| P/E Post-IPO | 18.28x |
Fabtech Technologies IPO Objectives
The IPO proceeds are proposed to be utilised as follows:
| Object | Amount (₹ Crore) |
| Funding working capital requirements | ₹1270.00 |
| Pursuing inorganic growth initiatives through acquisitions | ₹300.00 |
| General Corporate Purposes | Balance |
Industry Outlook
Fabtech Technologies operates in the biopharma and cleanroom technology sectors, which are witnessing increased demand driven by:
- Rapid growth in the global biopharma industry
- Rising regulatory standards for life sciences and cleanroom applications
- Increasing focus on process automation and advanced HVAC systems
- Growing demand for clean water and clean air solutions
With its diverse service offerings, strong market presence, and specialised expertise, Fabtech Technologies is well-positioned to capitalise on these trends and expand its footprint.
Conclusion
Fabtech Technologies Ltd. offers a promising investment opportunity with its focus on biopharma engineering and cleanroom technologies. The company’s strong growth trajectory, solid financials, and diverse order book make it an attractive proposition. However, potential investors should assess risks associated with sector competition, market conditions, and execution capabilities.
If you are exploring more investment opportunities, check out our dedicated page on upcoming IPO to stay updated on the latest market offerings.
